Related Experiment Video
Updated: Sep 24, 2025

29:02
Cell Capture Using a Microfluidic Device
Published on: October 1, 2007
5.5K
Efficient release of immunocaptured cells using coiled-coils in a microfluidic device.
Mengen Zhang1, Bin Xu1, Allison Siehr1
1Department of Biomedical Engineering, University of Minnesota Minneapolis MN 55455 USA shenx104@umn.edu +1-612-624-3771.
RSC Advances
|May 9, 2022
Summary
This study introduces a microfluidic platform for efficient cell capture and release using self-assembling coiled-coils. The method ensures cell integrity, offering a novel approach for cell separation without altering cell phenotype or function.
Area of Science:
- Biotechnology
- Microfluidics
- Cell Biology
Background:
- Label-free and affinity-based cell separation methods face challenges in efficiently releasing captured cells without compromising their integrity.
- Maintaining cell structure, phenotype, and function post-separation is crucial for downstream applications.
Purpose of the Study:
- To develop a microfluidic platform for label-free immunocapture and efficient release of target cells.
- To achieve cell release with minimal biochemical and biophysical perturbations, preserving cell characteristics.
Main Methods:
- Utilized a microfluidic system employing self-assembling heterodimerizing coiled-coils (A and B) for cell capture.
- Functionalized microchannels with antibodies and coiled-coil A for target cell capture.
- Employed a liquid flow containing B-PEG (coiled-coil B conjugated with polyethylene glycol) at controlled low shear stress for cell release.
Main Results:
- Achieved high capture selectivity (96.3% ± 1.8%) and release efficiency (92.5% ± 3.8%) for human umbilical vein endothelial cells (HUVECs).
- Demonstrated minimal perturbation to released cells, with no attached antibodies or cleaved surface molecules.
- Quantified a capture capacity of 10,735 ± 1897 cells per cm2 at a shear stress of 1 dyn cm-2.
Conclusions:
- The developed microfluidic platform enables efficient and gentle isolation of target cells.
- The B-PEG conjugate serves as a universal trigger for cell release, adaptable for various cell types recognizable by antibodies.
- This technology offers a promising solution for cell separation while preserving cell viability and function.

